Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Median duration analysis showed that liraglutide had a 148-day persistence advantage over dulaglutide as first-line therapy
and potentially early insight into health system impact, e.g., cost offsets, or trends in population-level outcomes related to obesity, e.g., prevalence, morbidity or mortality
At the same time, pharmaceutical companies have faced increasing public and regulatory pressure to lower self-pay (cash) prices for these medications though pricing and discount programs vary by drug and pharmacy
Sex differences in obesity, lipid metabolism, and inflammationA role for the sex chromosomes
US$ 27.25
US$ 22.85
US$ 24.86
US$ 22.19
